Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.38 |
| ▸ | FDPS | P14324 | 3/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | LCK | P06239 | 1/20 | 0.37 |
| ▸ | PPARD | Q03181 | 1/20 | 0.37 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.37 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11572649 | 1.00 | TP53 (0.46) | TP53SMPD1GPR84FDPSFFAR1 | |
| SCHEMBL7533698 | 1.00 | TP53 (0.46) | TP53SMPD1GPR84FDPSFFAR1 | |
| SCHEMBL11515407 | 1.00 | TP53 (0.46) | TP53SMPD1GPR84FDPSFFAR1 | |
| SCHEMBL318193 | 0.98 | TP53 (0.47) | TP53SMPD1GPR84FDPSFFAR1 | |
| SCHEMBL27843339 | 0.96 | TP53 (0.46) | TP53SMPD1GPR84FDPSFFAR1 | |
| Methylamine SCHEMBL28297217 | 0.94 | TP53 (0.48) | TP53SMPD1GPR84FDPSCA1 | |
| Trimethylammonium SCHEMBL28467227 | 0.93 | TP53 (0.43) | TP53SMPD1GPR84FDPSFFAR1 | |
| SCHEMBL24091301 | 0.92 | TP53 (0.48) | TP53SMPD1GPR84FDPSFFAR1 | |
| SCHEMBL1931553 | 0.92 | TP53 (0.48) | TP53SMPD1GPR84FDPSFFAR1 | |
| SCHEMBL14431494 | 0.92 | PTPN1 (0.40) | TP53FDPSCA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103228252-B | Comprise the composition and method of making the same of near-end hyperbranched compounds | THE PROCTER & GAMBLE CO. (US) | 2016-01-20 | — | — | CN | claimed |
| CN-103228252-A | Compositions comprising a near terminal-ranched compound and methods of making the same | PROCTER & GAMBLE | 2013-07-31 | — | — | CN | claimed |
| EP-2593074-A2 | COMPOSITIONS COMPRISING A NEAR TERMINAL-BRANCHED COMPOUND AND METHODS OF MAKING THE SAME | The Procter and Gamble Company (US) | 2013-05-22 | — | — | EP | claimed |
| US-20130053300-A1 | Compositions Comprising A Near Terminal-Branched Compound And Methods Of Making The Same | THE PROCTER & GAMBLE COMPANY | 2013-02-28 | — | — | US | claimed |
| WO-2012009525-A2 | COMPOSITIONS COMPRISING A NEAR TERMINAL-BRANCHED COMPOUND AND METHODS OF MAKING THE SAME | THE PROCTER & GAMBLE COMPANY (US) | 2012-01-19 | — | — | WO | claimed |
| CN-103228252-B | Comprise the composition and method of making the same of near-end hyperbranched compounds | THE PROCTER & GAMBLE CO. (US) | 2016-01-20 | — | — | CN | disclosed |
| US-8883698-B2 | Compositions comprising a near terminal-branched compound and methods of making the same | THE PROCTER & GAMBLE CO (US) | 2014-11-11 | — | — | US | disclosed |
| CN-103228252-A | Compositions comprising a near terminal-ranched compound and methods of making the same | PROCTER & GAMBLE | 2013-07-31 | — | — | CN | disclosed |
| EP-2593074-A2 | COMPOSITIONS COMPRISING A NEAR TERMINAL-BRANCHED COMPOUND AND METHODS OF MAKING THE SAME | The Procter and Gamble Company (US) | 2013-05-22 | — | — | EP | disclosed |
| US-20130053300-A1 | Compositions Comprising A Near Terminal-Branched Compound And Methods Of Making The Same | THE PROCTER & GAMBLE COMPANY | 2013-02-28 | — | — | US | disclosed |
| WO-2012009525-A2 | COMPOSITIONS COMPRISING A NEAR TERMINAL-BRANCHED COMPOUND AND METHODS OF MAKING THE SAME | THE PROCTER & GAMBLE COMPANY (US) | 2012-01-19 | — | — | WO | disclosed |